Currently accepted at: JMIR Research Protocols
Date Submitted: Dec 8, 2025
Date Accepted: Nov 16, 2026
This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/89184
The final accepted version (not copyedited yet) is in this tab.
Multimodal Diagnostics in Post-COVID: protocol of a matched-pair case-control study
ABSTRACT
Background:
Post-COVID (PC) syndrome affects 10–35% of individuals after SARS-CoV-2 infection, presenting with fatigue, dizziness, cognitive dysfunction, cardiac symptoms, and post-exertional malaise. Its pathophysiology remains poorly understood, with evidence implicating chronic inflammation, microvascular impairment, mitochondrial dysfunction, and autonomic dysregulation.
Objective:
The aim is to identify objective pathophysiological correlates of PC through comprehensive, multimodal assessments across microvascular, mitochondrial, and multi-organ functions.
Methods:
We designed a single-center, cross-sectional matched case-control study to investigate PC pathophysiology. Sixty-one participants with PC and 61 age- and sex-matched controls will undergo two consecutive days of multimodal assessments. Evaluations include advanced MRI of the brain, heart, lungs, and skeletal muscle; phosphorus-31 magnetic resonance spectroscopy; near-infrared spectroscopy; surface electromyography; critical flicker fusion frequency testing; video nailfold capillaroscopy; echocardiography including heart rate variability; body plethysmogra-phy; cardiopulmonary exercise testing; and laboratory analyses. This protocol enables simultaneous assessment of microvascular structure and function, mitochondrial energetics, and multi-organ dysfunction.
Results:
This methods manuscript describes the feasibility, implementation, and reproducibility of the protocol, including recruitment strategies, data acquisition workflows, and quality control procedures. Planned analyses will allow identification of objective pathophysiological correlates of PC.
Conclusions:
This comprehensive protocol provides a framework to study multi-organ dysfunction in PC. By integrating imaging, physiological, and laboratory assessments, it aims to generate objective biomarkers, improve risk stratification, reduce patient stigmatization, and inform evidence-based therapies for this complex syndrome affecting millions worldwide. Clinical Trial: German Register of Clinical Studies (DRKS; ID: DRKS00036987
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.